Publication:
Delivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regions

dc.contributor.authorSirikarn Tangcheewinsirikulen_US
dc.contributor.authorSwee Ping Tangen_US
dc.contributor.authorNicola Smithen_US
dc.contributor.authorMaynart Sukharomanaen_US
dc.contributor.authorSirirat Charuvanijen_US
dc.contributor.authorSoamarat Vilaiyuken_US
dc.contributor.authorThaschawee Arkachaisrien_US
dc.contributor.authorChristiaan Scotten_US
dc.contributor.authorHelen E. Fosteren_US
dc.contributor.otherSiriraj Hospitalen_US
dc.contributor.otherNewcastle University Medicine Malaysiaen_US
dc.contributor.otherFaculty of Medicine Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherKK Women's And Children's Hospitalen_US
dc.contributor.otherNewcastle Universityen_US
dc.contributor.otherUniversity of Cape Townen_US
dc.contributor.otherHospital Selayangen_US
dc.date.accessioned2022-08-04T09:05:58Z
dc.date.available2022-08-04T09:05:58Z
dc.date.issued2021-12-01en_US
dc.description.abstractBackground: Paediatric rheumatic diseases are a leading cause of acquired disability in Southeast Asia and Asia-Pacific Countries (SE ASIA/ASIAPAC). The aims of this study were to identify and describe the challenges to the delivery of patient care and identify solutions to raise awareness about paediatric rheumatic diseases. Methods: The anonymised online survey included 27 items about paediatric rheumatology (PR) clinical care and training programmes. The survey was piloted and then distributed via Survey-Monkey™ between March and July 2019. It was sent to existing group lists of physicians and allied health professionals (AHPs), who were involved in the care pathways and management of children with rheumatic diseases in SE ASIA/ASIAPAC. Results: Of 340 participants from 14 countries, 261 participants had been involved in PR care. The majority of the participants were general paediatricians. The main reported barriers to providing specialised multidisciplinary service were the absence or inadequacy of the provision of specialists and AHPs in addition to financial issues. Access to medicines was variable and financial constraints cited as the major obstacle to accessing biological drugs within clinical settings. The lack of a critical mass of specialist paediatric rheumatologists was the main perceived barrier to PR training. Conclusions: There are multiple challenges to PR services in SE ASIA/ASIAPAC countries. There is need for more specialist multidisciplinary services and greater access to medicines and biological therapies. The lack of specialist paediatric rheumatologists is the main barrier for greater access to PR training.en_US
dc.identifier.citationPediatric Rheumatology. Vol.19, No.1 (2021)en_US
dc.identifier.doi10.1186/s12969-021-00498-1en_US
dc.identifier.issn15460096en_US
dc.identifier.other2-s2.0-85099858634en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/77642
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099858634&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleDelivery of paediatric rheumatology care: a survey of current clinical practice in Southeast Asia and Asia-Pacific regionsen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85099858634&origin=inwarden_US

Files

Collections